QuidelOrtho (QDEL) Research & Development (2021 - 2024)

QuidelOrtho has disclosed Research & Development across 4 years of filings, most recently posting $59.2 million for Q1 2024.

• Research & Development for Q1 2024 came in at $59.2 million, down 4.98% year-over-year; the trailing twelve-month figure through Mar 2024 was $303.2 million (up 8.13% YoY), and the FY2024 annual result was $218.7 million, down 10.73% from the prior year.
• Research & Development came in at $59.2 million for Q1 2024 at QuidelOrtho, down from $118.8 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $118.8 million in Q4 2023 to a low of $22.6 million in Q3 2021.
• The 4-year median for Research & Development is $62.3 million (2023), against an average of $59.7 million.
• Across the five-year window, Research & Development jumped 176.79% in 2022 and decreased 4.98% in 2024, its largest moves.
• QuidelOrtho's Research & Development stood at $23.7 million in 2021, then surged by 176.79% to $65.6 million in 2022, then jumped by 81.1% to $118.8 million in 2023, then sank by 50.17% to $59.2 million in 2024.
• The last three Research & Development figures came in at $59.2 million (Q1 2024), $118.8 million (Q4 2023), and $62.4 million (Q4 2023), per Business Quant data.